Filing Flows › CVS Health (CVS) › Guidance history
CVS Health (CVS) guidance history: what it guided and what it reported
CVS Health gave guidance in 11 earnings releases on file since Feb 7, 2024. Its releases raised guidance 6 times and lowered it 3 times.
GAAP EPS
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $5.94–$6.14 (Feb 10, 2026) → raised $6.24–$6.44 (May 6, 2026) → raised $6.84–$7.04 (Aug 5, 2026) → raised $6.98 (Nov 4, 2026) | — | to be reported | — |
| FY2025 | $4.58–$4.83 (Feb 12, 2025) → lowered $4.23–$4.43 (May 1, 2025) → lowered $3.84–$3.94 (Jul 31, 2025) → lowered −$0.34–−$0.24 (Oct 29, 2025) | — | — | — |
| FY2024 | $7.06 (Feb 7, 2024) → lowered $5.64 (May 1, 2024) → lowered $4.95–$5.20 (Aug 7, 2024) | — | — | — |
Operating cash flow
The GAAP figure from the filings is shown for each period reported; it is not judged against the guide, which may leave items out (one-off payments, acquisitions).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $9.0B (Feb 10, 2026) | — | to be reported | — |
| FY2025 | $6.5B (Feb 12, 2025) → raised $7.0B (May 1, 2025) → raised $7.5B (Jul 31, 2025) → raised $7.5B–$8.0B (Oct 29, 2025) | $10.6B (GAAP) | not judged | — |
| FY2024 | $12.0B (Feb 7, 2024) → lowered $10.5B (May 1, 2024) → lowered $9.0B (Aug 7, 2024) | $9.1B (GAAP) | not judged | — |
Adjusted EPS
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $7.00–$7.20 (Feb 10, 2026) → raised $7.30–$7.50 (May 6, 2026) → raised $7.90–$8.10 (Aug 5, 2026) → raised $8.20 (Nov 4, 2026) | — | to be reported | — |
| FY2025 | $5.75–$6.00 (Feb 12, 2025) → raised $6.00–$6.20 (May 1, 2025) → raised $6.30–$6.40 (Jul 31, 2025) → raised $6.55–$6.65 (Oct 29, 2025) | — | — | — |
| FY2024 | $8.30 (Feb 7, 2024) → lowered $7.00 (May 1, 2024) → lowered $6.40–$6.65 (Aug 7, 2024) | — | — | — |
The latest quarter
CVS Health, Q3 2026: revenue $108.4B (+5% year over year), operating margin 3.3%, net earnings $2.2B, operating cash flow $4.7B. The chart follows the revenue to costs, profit and cash.
Questions
Does CVS Health beat its guidance?
CVS Health gave guidance in 11 earnings releases on file since Feb 7, 2024. Its releases raised guidance 6 times and lowered it 3 times.
How often does CVS Health raise guidance?
Its earnings releases raised guidance 6 times and lowered it 3 times since Feb 7, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.